The NICO Myriad is now in the hands of TV stars operating on a baby with a hypothalamic hamartoma who had laughing seizures. Sound familiar? The script mirrors the story of Nico Bastolla, who NICO was named after, and will feature the Myriad in an episode of the new TNT medical drama series, Monday Mornings.
Attractiveness of medical plastics processing assets is extremely high and heading higher. As a result, there is significant payback in investment in new equipment for American medical molders and extruders. Venture capital firms that have invested heavily in America medical plastics processing assets in the last five years include: Kohlberg & Co. (Phillips Plastics), Baird Capital Partners and River Cities Capital Funds (MedPlast), and KRG Capital Partners (Vention).
Just what does it take to be a CEO of a successful med-tech startup? What does the journey look like for a CEO that has made it through the process of taking an idea and building a product and business around it? Those questions were answered during the CEO Roundtable at the Southeastern Medical Device Conference (SEMDA), which included the CEO of River Cities Capital Funds’ portfolio company EndoChoice.
New sales and marketing solution helps companies quickly and easily discover and use their best proposals, presentations and other collateral.
River Cities’ Rik Vandevenne and portfolio company KnowledgeTree’s CEO Daniel Chalef discuss tips for entrepreneurs seeking venture funding.
River Cities’ portfolio company Knowlagent, the leading provider of intraday management solutions, is rebranding itself as Intradiem.
To expand its line of endoscopy technology, River Cities’ portfolio company EndoChoice will merge with Peer Medical.
NineSigma featured on HiVelocityMedia.com regarding the importance of open innovation for middle market companies.
Trax Technologies, a global provider of technology-driven solutions that enable shippers and logistics-service providers to efficiently and effectively manage their logistics spend and receivables, raised $10 million in a Series B round of financing led by River Cities Capital Funds.
Irv Shapiro, CEO and CTO, interviewed about the company’s success.